Open AccessCombining Clofarabine/Fludarabine with Exposure Targeted Busulfan for Pediatric Leukemia Is an Effective, Low Toxic TBI-Free Conditioning Regimen
Author(s) -
A. Birgitta Versluijs,
Coco de Koning,
Arjan C. Lankester,
Dorine Bresters,
Wouter J.W. Kollen,
Caroline A. Lindemans,
Stefan Nierkens,
Marc Bierings,
Jaap Jan Boelens
Publication year - 2020
Publication title -
biology of blood and marrow transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.301
H-Index - 120
eISSN - 1523-6536
pISSN - 1083-8791
DOI - 10.1016/j.bbmt.2019.12.578
Subject(s) - medicine , busulfan , fludarabine , clofarabine , minimal residual disease , oncology , regimen , transplantation , myeloid leukemia , surgery , hematopoietic stem cell transplantation , leukemia , cytarabine , chemotherapy , cyclophosphamide
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom